TIMBLIZ
Live / Applied — Non-final action mailed (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 17 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99448697
- Mark type
- Stylized text
- Filed
- 17 Oct 2025
- Attorney of record
- Christopher D Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical beta-blocker preparations; Pharmaceutical beta-blocker preparations in the form of a topical gel; Ophthalmic preparations containing timolol; Pharmaceutical preparations for the treatment of high blood pressure, glaucoma, and migraines; Pharmaceutical preparations for the treatment of elevated intraocular pressure in ocular hypertension or open angle glaucoma; Pharmaceutical preparations for the treatment of skin conditions, namely, infantile hemangiomas and chronic venous leg ulcers; Medicated cosmetics
Owner
- Auson Pharmaceuticals Inc., Bridgewater, NJ, US
Prosecution history
- 05 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Mar 2026 — NON-FINAL ACTION E-MAILED
- 05 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 03 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2025 — NEW APPLICATION ENTERED